CRESCENT BIOPHARMA, INC. (CBIO) Return on equity 2016–2025
CRESCENT BIOPHARMA, INC. (CBIO) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
0.1%FY2025 · since FY2016: -90.1% → 0.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 0.1% | — |
| FY2023 | 0.1% | +108.9 pp |
| FY2022 | -108.8% | -31.0 pp |
| FY2021 | -77.7% | -37.9 pp |
| FY2020 | -39.8% | — |
| FY2016 | -90.1% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice